SCULLY WILLIAM P purchased $920K of PRTA
SCULLY WILLIAM P purchased 110,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at an average of $8.36 ($8.35–$8.46, $0.92M total) across 2 trades over 2026-10-13 to 2026-10-14.
How this was made
The 30-second read
Why it matters
This is primarily a sentiment datapoint. Traders may monitor for follow-on insider activity, but the filing alone does not change PRTA fundamentals.
Market read
Insider buying can modestly influence near-term sentiment, but there is no new company-specific catalyst in the text.
What to watch
The filing does not disclose intent, tax considerations, or whether the purchase is part of a broader pattern; without follow-on company catalysts, price impact is likely limited.
Background
The article is an SEC Form 4 insider transaction disclosure for Prothena Corp, showing an open-market purchase by a 10% owner.
Ticker impact
Prothena Corp insider William P. Scully, a 10% owner, bought 110,000 shares in open-market trades at about $8.36 weighted average, per Form 4 filed Oct. 15.
Likely mild support or sentiment lift, with limited follow-through because the disclosure is an insider purchase rather than company guidance or a deal.
Form 4 insider buying can be read as confidence, but the article provides no accompanying company-specific news (no guidance, trial, or transaction) that would materially reprice the stock.
Market effects
Minimal, as this is a single-company insider transaction with no sector-wide signal.
None.
None.
Counterpoint
Insider purchases can be routine liquidity or portfolio rebalancing, and the lack of a 10b5-1 plan does not guarantee a directional fundamental view.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Company whose Form 4 insider purchase is disclosed.
- insiderSCULLY WILLIAM P
10% owner who purchased 110,000 shares in open-market trades.
